Sellars C, Hughes T, Langhorne P
Department of Speech and Language Therapy, Glasgow Royal Infirmary, Castle Street, Glasgow, UK, G4 0SF.
Cochrane Database Syst Rev. 2005 Jul 20(3):CD002088. doi: 10.1002/14651858.CD002088.pub2.
Dysarthria is a common sequel of non-progressive brain damage (typically stroke and traumatic brain damage). Impairment-based therapy and a wide variety of compensatory management strategies are undertaken by speech and language therapists with this patient population.
To determine the efficacy of speech and language therapy interventions for adults with dysarthria following non-progressive brain damage.
We searched the trials registers of the following Cochrane Groups: Stroke, Injuries, Movement Disorders and Infectious Diseases. We also searched the trials register of the Cochrane Rehabilitation and Related Therapies Field. The trials registers were last searched in September 2004. The Cochrane Central Register of Controlled Trials (CENTRAL) (The Cochrane Library Issue 2, 2004), MEDLINE (1966 to September 2004), EMBASE (1980 to September 2004), CINAHL (1983 to September 2004), PsycINFO (1974 to October 2004), and Linguistics and Language Behavior Abstracts (1983 to December 2004) were searched electronically. We handsearched the International Journal of Language and Communication Disorders (1966 to 2005, Issue 1) and selected conference proceedings, and scanned the reference lists of relevant articles. We approached colleagues and speech and language therapy training institutions to identify other possible published and unpublished studies.
Unconfounded randomised controlled trials (RCTs).
One author assessed trial quality. Two co-authors were available to examine any potential trials for possible inclusion in the review.
No trials of the required standard were identified.
AUTHORS' CONCLUSIONS: There is no evidence of the quality required by this review to support or refute the effectiveness of speech and language therapy interventions for dysarthria following non-progressive brain damage. Despite the recent commencement of a RCT of optimised speech and language therapy for communication difficulties after stroke, there continues to be an urgent need for good quality research in this area.
构音障碍是非进行性脑损伤（通常为中风和创伤性脑损伤）的常见后遗症。言语和语言治疗师针对这类患者群体采用基于损伤的疗法以及各种各样的代偿性管理策略。
确定针对非进行性脑损伤后患有构音障碍的成年人进行言语和语言治疗干预的疗效。
我们检索了以下Cochrane协作网小组的试验注册库：中风、损伤、运动障碍和传染病。我们还检索了Cochrane康复及相关疗法领域的试验注册库。试验注册库最近一次检索时间为2004年9月。通过电子方式检索了Cochrane对照试验中心注册库（CENTRAL）（Cochrane图书馆2004年第2期）、MEDLINE（1966年至2004年9月）、EMBASE（1980年至2004年9月）、CINAHL（1983年至2004年9月）、PsycINFO（1974年至2004年10月）以及语言学和语言行为摘要（1983年至2004年12月）。我们手工检索了《国际语言与交流障碍杂志》（1966年至2005年，第1期）并挑选了会议论文集，还浏览了相关文章的参考文献列表。我们联系了同事以及言语和语言治疗培训机构以确定其他可能已发表和未发表的研究。
无混杂因素的随机对照试验（RCT）。
由一位作者评估试验质量。有两位共同作者可审查任何可能纳入本综述的潜在试验。
未识别出符合要求标准的试验。
没有本综述所要求质量的证据来支持或反驳针对非进行性脑损伤后构音障碍进行言语和语言治疗干预的有效性。尽管最近开始了一项关于中风后沟通困难的优化言语和语言治疗的随机对照试验，但该领域仍然迫切需要高质量的研究。
